BMC Infectious Diseases: Advancing Infectious Disease Research in Support of SDG 3
Published in Microbiology, Biomedical Research, and General & Internal Medicine
Infectious diseases continue to shift and evolve, reshaping the health needs of communities around the world. At BMC Infectious Diseases, we’ve seen a growing urgency for research that not only deepens scientific understanding but also directly supports global health efforts, including the shared ambition of SDG 3: Good Health and Well‑Being.
As part of the upcoming SDG 3 newsletter on Infectious Diseases, we want to spotlight four of our newest Collections. Each Collection focuses on a critical area where evidence is needed, innovation is emerging, and global collaboration has the potential to move the needle on public health.
Personalized Medicine in Infectious Diseases
The promise of personalized medicine is no longer abstract in infectious disease research, it’s here, and it’s moving quickly. Where treatments once relied on broad, standardized approaches, precision diagnostics and genomics are opening the door to more tailored, effective interventions.
Guest edited by Dr Emma Sweeney and Dr Zhenwei Yu, this Collection on Personalized Medicine in Infectious Diseases brings together research exploring biomarker‑driven diagnostics, individualized antimicrobial strategies, and model‑informed dosing, all essential tools in addressing treatment resistance and improving patient outcomes.
Research in this space directly supports SDG 3 by strengthening our ability to deliver safer, more precise care.
Innovations in HIV Testing, Surveillance, and Treatment
Despite remarkable scientific progress, HIV remains one of the world’s most persistent health challenges. Guest edited by Dr Tiffany Phillips and Dr Bin Su, the Innovations in HIV Testing, Surveillance, and Treatment Collection focuses on what’s new and what’s next: rapid and point‑of‑care diagnostics, improved surveillance methods, long‑acting therapeutics, and strategies that make “test and treat” more accessible and effective.
As countries work toward the SDG 3.3 target of ending communicable disease epidemics, the research shared in our Collection supports more responsive, equitable, and accessible HIV care for communities everywhere.
Malaria in the 21st Century: Diagnostics, Resistance, and Control Strategies
Malaria control is at a pivotal moment. Advances in molecular diagnostics and vaccine development offer new promise, while resistance continues to pose familiar obstacles.
Guest edited by Dr Rajesh Chandramohanadas, Dr Loick P. Kojom Foko, Professor Ayodhia Pitaloka Pasaribu, and Dr Duoquan Wang, the Malaria in the 21st Century: Diagnostics, Resistance, and Control Strategies Collection invites research that deepens our understanding of evolving parasite biology, strengthens detection and surveillance, and supports robust control strategies.
These insights are essential for informing more resilient public health strategies and supporting the SDG 3.3 efforts towards malaria control and elimination.
Tropical Vector‑Borne Infectious Diseases
Vector‑borne infections, such as dengue, Zika, and chikungunya, continue to expand in geographical reach and intensity. With climate change and urbanization reshaping transmission patterns, understanding these diseases has never been more important.
Guest edited by Dr Maíra Aguiar, Dr Shengzhang Dong, Dr Marta Giovanetti, and Dr Wasin Matsee, this Collection on Tropical Vector‑Borne Infectious Diseases presents research on surveillance approaches, ecological drivers, diagnostic improvements, and integrated vector management strategies.
Strengthening evidence in this area supports communities most affected by vector‑borne outbreaks and aligns closely with SDG 3’s focus on epidemic preparedness.
Looking Ahead
Taken together, these four Collections illustrate the amount of work needed to understand and respond to infectious diseases in a rapidly changing world. Each opens space for interdisciplinary collaboration, innovative thinking, and research that can generate real‑world impact.
We look forward to seeing how the research community continues to push the field forward and to sharing the work that emerges through these Collections.
Do you want to join the conversation and submit your research? Explore these topics and more on the BMC Infectious Diseases Collections and Calls for Papers page.
This blog was written as part of April’s upcoming SDG 3 Newsletter on Infectious Diseases. To read the full newsletter as soon as it lands, follow Alice Coe and Virginia Mercer on Research Communities.
Follow the Topic
-
BMC Infectious Diseases
This journal is an open access, peer-reviewed journal that considers articles on all aspects of the prevention, diagnosis and management of infectious and sexually transmitted diseases in humans, as well as related molecular genetics, pathophysiology, and epidemiology.
Related Collections
With Collections, you can get published faster and increase your visibility.
Infectious disease management in infants and children
BMC Infectious Diseases invites submissions for a Collection on Infectious diseases in infants and children.
Infectious diseases in infants and children represent a significant burden on healthcare systems globally, often leading to serious complications, long-term health issues, and even mortality. This Collection aims to explore the diverse range of infectious diseases that specifically affect the pediatric population, including but not limited to respiratory infections, gastrointestinal infections, and vaccine-preventable diseases. Understanding the unique immune responses and vulnerabilities of young children is crucial for developing effective prevention and treatment strategies tailored to their needs.
The continued research into pediatric infectious diseases is vital for several reasons. Advances in immunization have significantly reduced the incidence of many vaccine-preventable diseases; however, challenges remain, particularly with the emergence of antimicrobial resistance and the resurgence of certain infections. Furthermore, the COVID-19 pandemic has underscored the importance of infection control measures in childcare, preschool, and school settings and highlighted the need for ongoing surveillance of childhood diseases. This area of research promises to contribute to improved health outcomes for infants and children worldwide.
With sustained research efforts, we can anticipate significant advances in the future, including the development of novel vaccines, improved diagnostics, and tailored treatment protocols. Continued exploration of the epidemiology of childhood diseases will further enhance our understanding of transmission dynamics and inform public health interventions.
We invite pediatricians, infectious disease specialists, public health professionals, immunologists, epidemiologists, and researchers in related fields to contribute original research articles on topics including but not limited to:
- Pediatric infectious diseases and their management
- Early childhood immunity and its implications
- Epidemiology of respiratory infections in children
- Antimicrobial resistance trends in pediatric settings
- Infection control in childcare, preschool, and school settings
This Collection supports and amplifies research related to SDG 3: Good Health and Well-being.
All manuscripts submitted to this journal, including those submitted to collections and special issues, are assessed in line with our editorial policies and the journal’s peer review process. Reviewers and editors are required to declare competing interests and can be excluded from the peer review process if a competing interest exists.
Publishing Model: Open Access
Deadline: Jun 30, 2026
Hepatitis virus infections and treatment
BMC Infectious Diseases invites submissions for a Collection on Hepatitis virus infections and treatment.
Hepatitis virus infections—including types A, B, C, D, and E—remain a significant global public health concern, collectively affecting hundreds of millions of people and contributing to a wide spectrum of liver-related diseases. These range from acute hepatitis and chronic liver inflammation to cirrhosis and hepatocellular carcinoma. Each hepatitis virus presents unique challenges in terms of transmission, disease progression, and treatment, with varying impacts across different regions and populations.
While hepatitis C has seen transformative progress with the development of Direct-Acting Antivirals (DAAs), hepatitis B continues to pose challenges due to its chronic nature and the need for lifelong management. Hepatitis A and E, typically transmitted via the fecal-oral route, are preventable through improved sanitation and vaccination, yet outbreaks still occur in resource-limited settings. Hepatitis D, which only occurs in conjunction with hepatitis B, adds complexity to diagnosis and treatment strategies.
Recent advances in diagnostics, therapeutics, and public health interventions have improved outcomes for many affected individuals. However, disparities in access to care, limited awareness, and gaps in screening and vaccination programs hinder global efforts to eliminate viral hepatitis as a public health threat. Continued research is essential to develop more effective prevention strategies, enhance treatment protocols, and understand the epidemiological and clinical nuances of each hepatitis virus. This Collection welcomes research that explores:
- Innovations in antiviral therapies across hepatitis types
- Epidemiology and transmission dynamics of hepatitis A–E
- Vaccine development and implementation strategies
- Novel diagnostic tools for acute and chronic hepatitis
- Public health approaches to hepatitis prevention and control
- Clinical implications of co-infections (e.g., HBV/HDV)
This Collection supports and amplifies research related to SDG 3: Good Health and Well-being.
All manuscripts submitted to this journal, including those submitted to collections and special issues, are assessed in line with our editorial policies and the journal’s peer review process. Reviewers and editors are required to declare competing interests and can be excluded from the peer review process if a competing interest exists.
Publishing Model: Open Access
Deadline: Jul 20, 2026
Please sign in or register for FREE
If you are a registered user on Research Communities by Springer Nature, please sign in